medtech
Commented by Armin Schulz on October 2nd, 2024 | 07:00 CEST
Evotec, Nyxoah, Carl Zeiss Meditec – Biotech and medtech stocks with potential
The biotechnology and medical technology industries are driving medical innovation and offering exciting investment opportunities. Evotec, Nyxoah, and Carl Zeiss Meditec stand out among the companies that are particularly prominent in these areas. Evotec has established itself through its collaborative strategy in drug discovery and is using modern technologies such as AI to accelerate the discovery process. The emerging medtech company Nyxoah is focusing on innovative solutions for the treatment of sleep apnea. Carl Zeiss Meditec is a leader in ophthalmology and microsurgery with world-class optical devices and advanced visualization technologies. All three companies have recently seen their stock prices come under pressure and now offer an entry opportunity.
Read
Commented by Juliane Zielonka on April 21st, 2022 | 13:58 CEST
Bayer AG, Perimeter Medical, Twitter - Shareholder interests drive share price performance
The life science and medical technology sectors offer investment opportunities. Whether with old hands like Bayer AG or up-and-coming innovative startups like Perimeter Medical, each company has its own fascination. Strong corporate management that acts in the interests of shareholders provides additional confidence. The latter, in particular, is currently being put to the test at the short messaging service Twitter. Elon Musk's takeover bid threatens to dilute existing investors' shares with a poison pill.
Read
Commented by André Will-Laudien on April 6th, 2022 | 10:46 CEST
Siemens Healthineers, Perimeter Medical, Siemens, SAP - After BioNTech, now the push for MedTech shares!
The most significant positive share price developments in the last 12 months occurred in the biotech sector, especially among vaccine manufacturers such as BioNTech and Moderna. The stock market overlooked that pandemics, and the fight against them, offer short-term profit opportunities. The great battle against widespread diseases such as cardiovascular disease, cancer or other previously incurable indications progresses steadily. Their diagnosis and treatment require many types of technology, devices, processes, analysis tools, and intelligent software. Some methods certainly deserve the attribute "disruptive technology". We take a look at some blockbusters in the MedTech segment.
Read
Commented by Armin Schulz on April 1st, 2022 | 12:54 CEST
Plug Power, Perimeter Medical Imaging AI, JinkoSolar - Shares for the future
Since the Ukraine crisis at the latest, it has been clear that the energy policy will have to look different in the future. While the end of fossil fuels has been heralded before, the transition must now happen faster than initially planned. Hydrogen could play a major role in heavy-duty transportation and energy-intensive industries. In electricity, renewables such as wind and solar power are expected to play a key role. But there are promising developments not only in the energy sector but also in medical technology. Cancer is on the rise worldwide, and any development that helps fight it is welcome. Today we look at stocks from the hydrogen, medical technology and solar power sectors.
Read
Commented by Carsten Mainitz on March 16th, 2022 | 11:18 CET
Valneva, Perimeter Medical Imaging AI, Bayer - Immune to the crisis?
No sooner did the Corona pandemic seem to be under control than the world was shocked by the invasion of Russian troops in Ukraine. So far, the stock markets have digested the whole situation well. But even without further escalation, the supply situation for raw materials, among other things, will become more complex. The first signs are already awaiting us at the gas pumps. The rise in inflation will continue. Where should one invest given this mixed situation? Regardless of the economic and security situation, stocks from the healthcare sector are a good choice. Beyond fighting viruses or infectious diseases, there are great growth areas. Cancer is one such area. In addition, medical technology is increasingly bringing innovative technologies to the market, in some cases in conjunction with artificial intelligence, with disruption potential.
Read
Commented by Fabian Lorenz on March 8th, 2022 | 12:07 CET
Nel, Hensoldt, Perimeter Medical: Hype share or sustainably attractive?
Since Russia's attack on Ukraine, the world has turned upside down. Also, the stock market. The volatility is extreme, as is the uncertainty of many investors. It is worth taking a look at companies in sectors with good long-term prospects. More than ever, these include renewable energies and, as of almost two weeks ago, "unfortunately" also the defense industry. Hydrogen is a key technology, and Nel ASA is a specialist in this field. However, insider sales are causing uncertainty. The same happened at Hensoldt after a major shareholder cashed in - but only for a short time. Medical technology is on the sidelines these days, although companies like Perimeter are working on life-saving technologies.
Read
Commented by Juliane Zielonka on February 24th, 2022 | 13:37 CET
Perimeter, PayPal, Porsche - In the fast lane with high-speed innovations
Tech values such as PayPal are currently losing a lot of ground. A wonderful exception in these turbulent times are MedTech companies like Perimeter Medical Imaging. The Company has commercialized an imaging technology that confidently assists surgeons in clinical decision-making, further enhancing patient safety in oncology. What is happening at high speed in the healthcare industry outside Germany is impressive. In contrast, Porsche's popular IPO is not quite getting off the ground yet. There are many talks to be held with various board members to bring the brand back to the family.
Read
Commented by André Will-Laudien on February 15th, 2022 | 12:30 CET
Attention: Siemens Healthineers, Perimeter Medical Imaging AI, MorphoSys, Siemens - Riding the next hype with MedTech!
MedTech and pharma giants have been in high demand not only since the pandemic. The technification of diagnostics leads to the early detection of serious diseases and shortens the planning of necessary medical interventions. Of course, COVID-19 significantly impacts the availability and additional demand for high-tech in practices and emergency departments. It is creating a boom in demand from manufacturers rarely seen at this headline rate. We are looking at clear winners in medical digitization.
Read
Commented by Armin Schulz on February 7th, 2022 | 12:14 CET
Bayer, Perimeter Medical Imaging AI, Siemens Healthineers - Diagnostics as an upcoming trend in the pharmaceutical industry
The Corona pandemic has made many people aware of the importance of diagnostics. Without PCR and antigen tests, it would have been impossible to control the incidence of infection. But it is not only in this area that things have changed in the last 2 years. Diagnostics are becoming increasingly digitized, and so more and more tech companies are entering the market that originally had nothing to do with the pharmaceutical industry. The better the diagnostics, the earlier diseases can be detected and treated. It is a future topic in pharma. We look at three companies from this sector today.
Read
Commented by Nico Popp on January 31st, 2022 | 11:56 CET
MedTech with billion-dollar potential: Siemens Healthineers, Perimeter Medical Imaging, Sartorius
When we think of medical technology, we often think of the big players like Siemens Healthineers or the Fresenius Group. But the MedTech sector is characterized mainly by small and medium-sized companies. This is shown by a survey conducted by the German Medical Technology Association (BVMed). The experts have seen rising sales for years in this very diverse sector. Reason enough to shed light on a promising market from an investor's perspective. We present three companies and their shares.
Read